Milestone Resources Group Ltd cut its stake in UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 0.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 220,014 shares of the healthcare conglomerate’s stock after selling 178 shares during the period. UnitedHealth Group comprises about 5.8% of Milestone Resources Group Ltd’s investment portfolio, making the stock its 6th largest position. Milestone Resources Group Ltd’s holdings in UnitedHealth Group were worth $103,976,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in the stock. Chelsea Counsel Co. purchased a new stake in UnitedHealth Group in the fourth quarter worth about $27,000. Freedom Wealth Alliance LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth about $31,000. Legend Financial Advisors Inc. purchased a new stake in UnitedHealth Group in the third quarter worth about $37,000. Investors Research Corp lifted its stake in UnitedHealth Group by 51.1% in the fourth quarter. Investors Research Corp now owns 71 shares of the healthcare conglomerate’s stock worth $38,000 after acquiring an additional 24 shares during the period. Finally, Bourgeon Capital Management LLC lifted its stake in UnitedHealth Group by 192.3% in the fourth quarter. Bourgeon Capital Management LLC now owns 76 shares of the healthcare conglomerate’s stock worth $40,000 after acquiring an additional 50 shares during the period. 92.61% of the stock is currently owned by institutional investors.
UnitedHealth Group Price Performance
UnitedHealth Group stock opened at $477.00 on Monday. The company’s fifty day moving average price is $485.19 and its 200 day moving average price is $491.96. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10. The stock has a market capitalization of $444.10 billion, a P/E ratio of 21.81, a P/E/G ratio of 1.39 and a beta of 0.68. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.81 and a current ratio of 0.81.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th will be issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.58%. The ex-dividend date is Thursday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.65. UnitedHealth Group’s payout ratio is currently 34.39%.
Analyst Upgrades and Downgrades
Several research firms have commented on UNH. SVB Securities decreased their price target on shares of UnitedHealth Group from $625.00 to $560.00 in a research report on Wednesday, June 14th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $592.00 price objective on shares of UnitedHealth Group in a research report on Monday, April 17th. StockNews.com lowered shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, June 14th. Stephens reiterated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a report on Tuesday, February 28th. Finally, Oppenheimer reiterated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Monday, April 17th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $592.68.
Insider Transactions at UnitedHealth Group
In other news, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the transaction, the chief executive officer now owns 86,564 shares in the company, valued at approximately $42,199,084.36. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, CEO Andrew Witty sold 6,160 shares of UnitedHealth Group stock in a transaction on Thursday, April 27th. The stock was sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the transaction, the chief executive officer now owns 86,564 shares in the company, valued at approximately $42,199,084.36. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,684 shares of the firm’s stock in a transaction dated Monday, April 24th. The stock was sold at an average price of $488.46, for a total value of $822,566.64. Following the sale, the executive vice president now directly owns 8,675 shares of the company’s stock, valued at $4,237,390.50. The disclosure for this sale can be found here. Insiders have sold a total of 8,852 shares of company stock worth $4,313,962 in the last quarter. Company insiders own 0.35% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Get a free research report on UnitedHealth Group from StockNews.com
- MarketBeat Week in Review – 6/19 – 6/23
- CarMax Stock Flying On Earnings Beat, Return Of The Highs?
- Commercial Metals Company Shakes Off The Rust: Confirms Uptrend
- Smith & Wesson, A Timeless Value Play At Decade Lows
- Five stocks we like better than UnitedHealth Group
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
